NPI Details
David A Richards, MD is an internal medicine in Somerset, NJ with 43 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. David A Richards, MD NPI is 1235129396. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: BIRMINGHAM MEDICAL COLLEGE
Graduation Year:1983
The provider's business location address is:
75 VERONICA AVE
STE 201
SOMERSET, NJ
ZIP 08873-002
Phone: (732) 246-4882
Fax: (732) 249-5633
The NPI 1235129396 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
- Injection, iron sucrose, 1 mg (HCPCS:J1756)
- Injection, pembrolizumab, 1 mg (HCPCS:J9271)
- Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
- Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
- Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
- Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
- Unclassified drugs (HCPCS:J3490)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
- Application of on-body injector for under skin injection (HCPCS:96377)
The enumeration date for this NPI number is 10/28/2005 and was last updated on 8/15/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207RH0003X | Internal Medicine | Hematology & Oncology | 25MA05444200 | NEW JERSEY | No |
| 2 | 207R00000X | Internal Medicine | | 25MA05444200 | NEW JERSEY | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 1235129396 | OTHER | NEW JERSEY | INDIVIDUAL NPI |
| 2 | 1265623169 | OTHER | NEW JERSEY | GROUP NPI |
| 3 | 1801850243 | OTHER | NEW JERSEY | RCCA GROUP NPI# |
| 4 | 1790396281 | OTHER | NEW JERSEY | TITAN HEALTH GROUP NPI# |
| 5 | 5426600 | OTHER | NEW JERSEY | RCCA GROUP MEDICAID # |
| 6 | 5608201 | MEDICAID | NEW JERSEY | |
| 7 | 295909 | OTHER | NEW JERSEY | RCCA GROUP MEDICARE # |
